465 related articles for article (PubMed ID: 19624546)
1. Quality of life in patients with epidermolysis bullosa.
Tabolli S; Sampogna F; Di Pietro C; Paradisi A; Uras C; Zotti P; Castiglia D; Zambruno G; Abeni D
Br J Dermatol; 2009 Oct; 161(4):869-77. PubMed ID: 19624546
[TBL] [Abstract][Full Text] [Related]
2. Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: an EB-specific quality of life instrument.
Frew JW; Martin LK; Nijsten T; Murrell DF
Br J Dermatol; 2009 Dec; 161(6):1323-30. PubMed ID: 19681875
[TBL] [Abstract][Full Text] [Related]
3. Family burden in epidermolysis bullosa is high independent of disease type/subtype.
Tabolli S; Pagliarello C; Uras C; Di Pietro C; Zambruno G; Castiglia D; Sampogna F; Abeni D
Acta Derm Venereol; 2010 Nov; 90(6):607-11. PubMed ID: 21057744
[TBL] [Abstract][Full Text] [Related]
4. Impact of inherited epidermolysis bullosa on parental interpersonal relationships, marital status and family size.
Fine JD; Johnson LB; Weiner M; Suchindran C
Br J Dermatol; 2005 May; 152(5):1009-14. PubMed ID: 15888161
[TBL] [Abstract][Full Text] [Related]
5. Quality of life and psychological morbidity in women with polycystic ovary syndrome: body mass index, age and the provision of patient information are significant modifiers.
Ching HL; Burke V; Stuckey BG
Clin Endocrinol (Oxf); 2007 Mar; 66(3):373-9. PubMed ID: 17302871
[TBL] [Abstract][Full Text] [Related]
6. Quality-of-life assessment in patients with pemphigus using a minimum set of evaluation tools.
Paradisi A; Sampogna F; Di Pietro C; Cianchini G; Didona B; Ferri R; Abeni D; Tabolli S
J Am Acad Dermatol; 2009 Feb; 60(2):261-9. PubMed ID: 19004524
[TBL] [Abstract][Full Text] [Related]
7. Protease inhibitor combination therapy, severity of illness, and quality of life among children with perinatally acquired HIV-1 infection.
Storm DS; Boland MG; Gortmaker SL; He Y; Skurnick J; Howland L; Oleske JM;
Pediatrics; 2005 Feb; 115(2):e173-82. PubMed ID: 15629958
[TBL] [Abstract][Full Text] [Related]
8. Measuring quality of life of patients with different clinical types of psoriasis using the SF-36.
Sampogna F; Tabolli S; Söderfeldt B; Axtelius B; Aparo U; Abeni D;
Br J Dermatol; 2006 May; 154(5):844-9. PubMed ID: 16634884
[TBL] [Abstract][Full Text] [Related]
9. Baseline Quality of Life in patients with Klippel-Trenaunay syndrome.
Oduber CE; Khemlani K; Sillevis Smitt JH; Hennekam RC; van der Horst CM
J Plast Reconstr Aesthet Surg; 2010 Apr; 63(4):603-9. PubMed ID: 19289309
[TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
11. [Caregiver burden in relatives of persons with schizophrenia: an overview of measure instruments].
Reine G; Lancon C; Simeoni MC; Duplan S; Auquier P
Encephale; 2003; 29(2):137-47. PubMed ID: 14567165
[TBL] [Abstract][Full Text] [Related]
12. Hand function and quality of life in children with epidermolysis bullosa.
Eismann EA; Lucky AW; Cornwall R
Pediatr Dermatol; 2014; 31(2):176-82. PubMed ID: 24274904
[TBL] [Abstract][Full Text] [Related]
13. Factors related to perceived quality of life in patients with Alzheimer's disease: the patient's perception compared with that of caregivers.
Conde-Sala JL; Garre-Olmo J; Turró-Garriga O; López-Pousa S; Vilalta-Franch J
Int J Geriatr Psychiatry; 2009 Jun; 24(6):585-94. PubMed ID: 19031477
[TBL] [Abstract][Full Text] [Related]
14. Epidermolysis bullosa in Finland. Clinical features, morphology and relation to collagen metabolism.
Kero M
Acta Derm Venereol Suppl (Stockh); 1984; 110():1-51. PubMed ID: 6331034
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal complications of inherited epidermolysis bullosa: cumulative experience of the National Epidermolysis Bullosa Registry.
Fine JD; Johnson LB; Weiner M; Suchindran C
J Pediatr Gastroenterol Nutr; 2008 Feb; 46(2):147-58. PubMed ID: 18223373
[TBL] [Abstract][Full Text] [Related]
16. Quality of life measurements in epidermolysis bullosa: tools for clinical research and patient care.
Frew JW; Murrell DF
Dermatol Clin; 2010 Jan; 28(1):185-90. PubMed ID: 19945634
[TBL] [Abstract][Full Text] [Related]
17. Willingness-to-pay and quality of life in patients with vitiligo.
Radtke MA; Schäfer I; Gajur A; Langenbruch A; Augustin M
Br J Dermatol; 2009 Jul; 161(1):134-9. PubMed ID: 19298268
[TBL] [Abstract][Full Text] [Related]
18. Development, reliability, and validity of a novel Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI).
Loh CC; Kim J; Su JC; Daniel BS; Venugopal SS; Rhodes LM; Intong LR; Law MG; Murrell DF
J Am Acad Dermatol; 2014 Jan; 70(1):89-97.e1-13. PubMed ID: 24355263
[TBL] [Abstract][Full Text] [Related]
19. Eye involvement in inherited epidermolysis bullosa: experience of the National Epidermolysis Bullosa Registry.
Fine JD; Johnson LB; Weiner M; Stein A; Cash S; Deleoz J; Devries DT; Suchindran C
Am J Ophthalmol; 2004 Aug; 138(2):254-62. PubMed ID: 15289135
[TBL] [Abstract][Full Text] [Related]
20. Dental caries risk in hereditary epidermolysis bullosa.
Wright JT; Fine JD; Johnson L
Pediatr Dent; 1994; 16(6):427-32. PubMed ID: 7854950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
